Question 1

What is the catalog number for Brilliant Violet 785™ anti-human CD269 (BCMA)?

Accepted Answer

The catalog number for Brilliant Violet 785™ anti-human CD269 (BCMA) is GT13940.

Question 2

What sizes are available for Brilliant Violet 785™ anti-human CD269 (BCMA)?

Accepted Answer

Brilliant Violet 785™ anti-human CD269 (BCMA) is available in the following size(s): 100 Tests.

Question 3

Is Brilliant Violet 785™ anti-human CD269 (BCMA) in stock?

Accepted Answer

Brilliant Violet 785™ anti-human CD269 (BCMA) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Question 5

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Brilliant Violet 785™ anti-human CD269 (BCMA)

Product Specifications

Reactivity

Isotype

Clone

Conjugation

Applications

Specificity

Frequently Asked Questions

Explore Other Products

Prolactin (Pituitary Tumor Marker) (PRL/2910), CF594 conjugate, 0.1mg/mL

Anti-Kallikrein 1/KLK1 Antibody Picoband®, Cy3 Conjugate

Anti-Caveolin-2/CAV2 Antibody Picoband®, HRP Conjugate

Mucin 6 (MUC6) (CLH5), CF568 conjugate, 0.1mg/mL

Neurofilament (H+L) (NF421 + NFL736), CF405S conjugate, 0.1mg/mL

CD73 (Immuno-Oncology Target) (NT5E/2646), CF647 conjugate, 0.1mg/mL